Py
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Py, covering 2022-01-05 to 2022-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP [Phase 4]